Published in Disease Risk Factor Week, August 28th, 2005
"Linking the Ii-Key functional group LRMK, through a simple polymethylene linker, to the melanoma gp 100(48-58) MHC class 11 epitope significantly enhances the vaccine response to that epitope in DR4-IE transgenic mice. A homologous series of IiKey/gp100(46-58) hybrids was synthesized to test the influence of spacer length (between Ii-Key and the gp100(48-58) epitope) on in vivo enhancement of gp100(48-58)-specific CD4+ T-lymphocyte responses," scientists writing in the Journal of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Disease Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.